Journal of APPLIED BIOMEDICINE
ISSN 1214-0287 (on-line)
ISSN 1214-021X (printed)

Volume 2 (2004), No 3, p 163-167




The therapeutic efficacy of oxime treatment in cyclosarin-poisoned mice pretreated with a combination of pyridostigmine benactyzine and trihexyphenidyl

Lucie Sevelova, Kamil Kuca, Gabriela Krejcova, Josef Vachek

Address: Lucie Sevelova, Purkyne Military Medical Academy, Department of Toxicology, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic
sevelova@pmfhk.cz

Received 30th January 2004.
Revised 20th March 2004.
Published online 25th April 2004.

Full text article (pdf)

SUMMARY
The present study was performed to assess and compare the therapeutic efficacy of various oximes (methoxime, BI-6, HI-6) combined with benactyzine (BNZ) in cyclosarin (GF-agent)- poisoned mice and to evaluate the influence of pretreatment with PANPAL (pyridostigmine, benactyzine and trihexyphenidyl) on the effect of antidotal treatment in mice poisoned with the GF-agent. In the first part of our experiment, methoxime, BI-6 or HI-6 in combination with benactyzine were used for the treatment of GF-poisoned mice. In the second part of the experiment the animals were pretreated with PANPAL 60 min before the GF-agent challenge and then the oxime therapy was applied in the same time scheme as before. All the therapeutic regimens showed a protective ratio higher than 2 and significantly increased the LD50 of GF-agent. The most efficacious oxime in decreasing of GF-agent toxicity was HI-6. PANPAL increased the protective ratios of all therapeutic regimens in comparison with administration of the oxime and BNZ alone. From the results obtained, the combination of pretreatment with PANPAL and following therapy with BNZ and HI-6 seems to be the most efficacious therapeutic regimen for treatment of GF-agent-poisoned mice.

KEY WORDS
GF-agent; cyclosarin; benactyzine; pyridostigmine; PANPAL; oxime


REFERENCES
Abou-donia MB, Goldstein LB, Jones KH, Abdel-Rahman AA, Damodaran TV, Dechkovskaia AM, Bullman SL, Amir BE, Khan WA: Locomotor and sensimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol Sci 60:305-314, 2001.

Bajgar J, Fusek J, Vachek J: Treatment and prophylaxis against nerve agent poisoning. ASA Newsl 94:10-11, 1994.

Berry WK, Davis DR: The use of carbamates and atropine in the protection of animals against poisoning with 1,2,2-trimethylpropylmethyl-phosphonofluoridate. Biochem Pharmacol 19:927-934, 1970.

Gouge SF Daniels DJ, Smith CE: Exacerbation of asthma after pyridostigmine during Operation Desert Storm Mil Med 159:108-111, 1994.

Kassa J: Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol 40:803-816, 2002.

Kassa J: The influence of anticholinergic drug selection on the effectiveness of oximes against soman-induced supralethal poisoning in mice. Acta Medica (Hradec Kralove) 44:77-79, 2001.

Kassa J, Bajgar J: Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methylphosphonofluoridate (GF) in rats. Hum Exp Toxicol 14:923-928, 1995.

Kassa J, Vachek J: A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned mice and rats. Toxicology 177:179-185, 2002.

Kassa J, Vachek J, Bajgar J, Fusek J: A combination of pyridostigmine with anticholinergic drugs:_effective pharmacological pretreatment of soman-poisoned mice. ASA Newslett 16:1-3, 2001.

Kuca K, Bielavsky J, Cabal J, Kassa J: Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg Med Chem Lett 13:3545-3547, 2003.

Kuca K, Patocka J: Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium oximes. J Enzyme Inhib Med Chem 19:39-43, 2004.

Lundy PM, Hansen AS, Hand BT, Boulet CA: Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 72:99-105, 1992.

Marrs TC: Organophosphate poisoning. Pharmacol Ther 58:51-66, 1993.

Ohtomi S, Takase S, Kumagai F: Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm 69:97-102, 1996.

Roth Z, Josifko M, Trcka V: Statisticke metody v experimentálni medicine. Statni zdravotnicke nakladatelstvi, Praha 1962, pp. 405-413.

Stefanidou M, Athanaselis S, Velonakis M, Pappas F, Koutselinis A: Occupational exposure to cholinesterase inhibiting pesticides: a Greek case. Int J Environ Health Res 13:23-29, 2003.

Tallarida R, Murray R: Manual of pharmacological calculation with computer programs. Springer Verlag, New York 1987, pp. 145.

Vachek J, Kassa J, Fusek J, Bajgar J: Present possibilities of treatment of organophosphate poisoning. Sbornik vedeckych praci VLA JEP Hradec Kralove 116:67, 1993.

Wenger B, Quigley MD, Kokla MA: Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat. Aviat Space Environ Med 64:905-911, 1993.

Worek F, Reiter G, Eyer P, Szinicz L: Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 76:523-529, 2002.
CITED

Lundy PM, Hamilton MG, Sawyer TW, Mikler J. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning. Toxicol. 285: 90-96, 2011.

Pohanka M, Sobotka J, Svobodova H, Stetina R. Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model. Drug Chem Toxicol. 34: 255-260, 2011.

Kuca K, Cabal J, Jun D, Koleckar V. In vitro comparison of two most promising H-oximes (HI-6 and HLo-7) and currently commercially available reactivators pralidoxime and obidoxime in reactivation of cyclosarin-inhibited human cholinesterases. Toxicol Mech Methods. 18: 329-333, 2008.

Kuca K, Jun D, Bajgar J. Structural factors influencing potency of currently used acetylc holineste rase reactivators for treatment of cyclosarin intoxications. Curr Pharm Design. 13: 3445-3452, 2007.

Sakurada K, Ikegaya H, Ohta H, Akutsu T, Takatori T. Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM). Toxicol Lett. 166: 255-260, 2006.

Kuca K, Jun D, Kirn TH, Cabal J, Jung YS. In vitro evaluation of new acetylcholinesterase reactivators as casual antidotes against tabun and cyclosarin. Bull Korean Chem Soc. 27: 395-398, 2006.

Kuca K, Jun D, Cabal J, Hrabinova M, Bartosova L, Opletalova V. Russian VX: Inhibition and reactivation of acetylcholinesterase compared with VX agent. Basic Clin Pharmacol Toxicol. 98: 389-394, 2006.

Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg Med Chem Lett. 16: 622-627, 2006.

Musilek K, Kuca K, Jun D, Dohnal V, Kim T-H, Jung Y-S, Dolezal M. Synthesis of reactivators of phosphorylated acetylcholinesterase of bis-pyridiniumdialdoxime type with a 3-oxapentane connecting chain and their testing in vitro on a model of the enzyme inhibited by chlorpyrifos and methylchlorpyrifos. Ceska a Slovenska Farmacie. 55: 115-119, 2006.

Krejcova Kunesova G, Bartosova L, Kuca K. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators. Toxicol. 216: 32-40, 2005.

Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enz Inh Med Chem. 20: 409-415, 2005.

Picha J, Kuca K, Kivala M, Kohout M, Cabal J, Liska F. A new group of monoquaternary reactivators of acetylcholinesterase inhibited by nerve agents. J Enz Inh Med Chem. 20: 233-237, 2005.

Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain. J Appl Toxicol. 25: 271-276, 2005.

Kuca K, Cabal J, Jun D, Kassa J, Bartosova L, Kunesova G. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J Appl Toxicol. 25: 296-300, 2005.

Kuca K, Cabal J, Kassa J. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods. J Toxicol Environ Health Part A. 68: 677-686, 2005.

Sevelova L, Kuca K, Krejcova Kunesova G. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes. Toxicology. 207: 1-6, 2005.

Cabal J, Kuca K, Jun D, Bajgar J, Hrabinova M. A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun. [Srovnavani ucinnosti reaktivatoru acetylcholinesterasy inhibovane tabunem]. Ceska a Slovenska Farmacie. 54: 192-195, 2005.

BACK